As insulin mediated suppression of hepatic gluconeogenesis is altered in MetS and type 2 diabetes mellitus [56,57], we investigated the effectiveness of GMP to bring this pathway to normality in obesogenic conditions. The gene discussed is INS; the disease is type 2 diabetes mellitus.